Detail akcie IQVIA Holdings Rg online

Business Summary: IQVIA Holdings Inc. is a global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries. Its segments include Technology & Analytics Solutions, Research & Development Solutions and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment provides mission-critical information, technology solutions and real-world insights and services to the Company’s life science clients. The Research & Development Solutions segment primarily serves biopharmaceutical customers, and provides outsourced clinical research and clinical trial-related services. The Contract Sales & Medical Solutions segment provides healthcare provider (including contract sales) and patient engagement services to both biopharmaceutical customers and the broader healthcare market. It offers a set of strategic and implementation consulting services, including advanced analytics and commercial processes outsourcing services.
Financial Summary: BRIEF: For the fiscal year ended 31 December 2025, Iqvia Holdings Inc revenues increased 6% to $16.31B. Net income decreased 1% to $1.36B. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Net income was offset by Interest Expense increase of 9% to $729M (expense), Restructuring costs increase of 57% to $105M (expense).